Northwestern Mutual Wealth Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-200	Closed	-$1K	–	2846
2019 Q1	$1K	Buy	+200	New	+$675	﹤0.01%	2503
2017 Q4	–	Sell	-174	Closed	-$1K	–	2557
2017 Q3	$1K	Buy	+174	New	+$484	﹤0.01%	2123
2017 Q1	–	Sell	-498	Closed	-$1K	–	2674
2016 Q4	$1K	Buy	+498	New	+$1.39K	﹤0.01%	2329
2016 Q3	–	Sell	-424	Closed	-$1K	–	2013
2016 Q2	$1K	Hold	424	–	–	﹤0.01%	2032
2016 Q1	$1K	Buy	+424	New	+$1.32K	﹤0.01%	2098
2015 Q1	–	Sell	-280	Closed	-$2K	–	2022
2014 Q4	$2K	Buy	+280	New	+$2.22K	﹤0.01%	1590

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Northwestern Mutual Wealth Management's PDLI Position: Q2 2019 in Review

Northwestern Mutual Wealth Management sold out of PDL BioPharma, Inc. (PDLI) in Q2 2019, closing a stake of 200 shares — an estimated $1K sold.

Northwestern Mutual Wealth Management first reported a position in PDLI in Q4 2014 and held it in 6 quarters. The position peaked at $2K in Q4 2014. 148 funds tracked by Wall St. Rank hold PDLI as of Q2 2019.

Northwestern Mutual Wealth Management reported no remaining PDL BioPharma, Inc. position as of Q2 2019 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 200 PDL BioPharma, Inc. shares in Q2 2019, an estimated $1K.
Northwestern Mutual Wealth Management first reported a position in PDL BioPharma, Inc. in Q4 2014 and held it in 6 quarters.
Northwestern Mutual Wealth Management's PDL BioPharma, Inc. position peaked at $2K in Q4 2014.
148 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q2 2019.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2019, filed 12 Aug 2019.